FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$31.23
+0 (+0%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $31.23 $31.23 Wednesday, 1st May 2024 IMGN stock ended at $31.23. During the day the stock fluctuated 0% from a day low at $31.23 to a day high of $31.23.
90 days $29.21 $31.25
52 weeks $10.31 $31.25

Historical ImmunoGen prices

Date Open High Low Close Volume
Dec 06, 2023 $29.20 $29.44 $29.17 $29.34 7 616 685
Dec 05, 2023 $29.15 $29.28 $29.11 $29.21 15 148 698
Dec 04, 2023 $29.10 $29.28 $29.05 $29.22 13 739 142
Dec 01, 2023 $29.25 $29.35 $28.94 $29.32 30 120 635
Nov 30, 2023 $29.20 $29.44 $28.76 $29.35 67 430 538
Nov 29, 2023 $16.07 $16.69 $15.88 $16.06 4 551 621
Nov 28, 2023 $16.12 $16.21 $15.67 $15.98 4 456 345
Nov 27, 2023 $16.16 $16.34 $15.84 $16.16 3 113 677
Nov 24, 2023 $16.15 $16.49 $15.92 $16.06 2 132 205
Nov 22, 2023 $15.28 $16.26 $15.14 $16.14 4 625 359
Nov 21, 2023 $14.82 $15.44 $14.74 $15.21 3 274 764
Nov 20, 2023 $15.66 $16.00 $14.77 $14.94 5 204 214
Nov 17, 2023 $15.71 $16.42 $15.61 $16.11 7 418 310
Nov 16, 2023 $15.48 $16.02 $15.35 $15.59 3 456 701
Nov 15, 2023 $15.61 $16.03 $15.56 $15.64 4 850 234
Nov 14, 2023 $15.46 $15.94 $15.18 $15.76 4 971 260
Nov 13, 2023 $14.53 $14.80 $14.26 $14.74 2 578 688
Nov 10, 2023 $14.76 $14.94 $14.26 $14.76 3 482 861
Nov 09, 2023 $15.95 $15.95 $14.62 $14.74 5 163 692
Nov 08, 2023 $15.92 $16.14 $15.56 $15.74 2 771 477
Nov 07, 2023 $16.22 $16.73 $15.79 $15.98 4 880 370
Nov 06, 2023 $15.96 $16.20 $14.88 $16.02 7 206 048
Nov 03, 2023 $15.86 $16.38 $15.25 $16.29 8 849 607
Nov 02, 2023 $15.70 $16.56 $15.23 $15.50 13 282 231
Nov 01, 2023 $14.58 $15.01 $14.46 $14.94 6 247 574
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT